ARDIZZONI, ANDREA

ARDIZZONI, ANDREA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Docenti di ruolo di Ia fascia  

Mostra records
Risultati 1 - 20 di 328 (tempo di esecuzione: 0.029 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; L...odi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano 2016-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 1.01 Articolo in rivista -
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocil...la, E; Ardizzoni, A; Fanti, S 2016-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 1.01 Articolo in rivista -
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti 2016-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 4.02 Riassunto (Abstract) -
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; A...rdizzoni A 2005-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.04 Replica / breve intervento (e simili) -
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E,... Ardizzoni A, Massari F 2018-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea 2018-01-01 INVESTIGATIONAL NEW DRUGS - 1.01 Articolo in rivista -
A Case of Response to Immunotherapy in a Patient With MSI Metastatic Colorectal Cancer and Autoimmune Disease in Steroid Therapy Massucci, Maria; Di Fabio, Francesca; Rojas Llimpe, Fabiola L; Ardizzoni, Andrea 2020-01-01 JOURNAL OF IMMUNOTHERAPY - 1.01 Articolo in rivista -
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation Cascinu S; Berardi R; Salvagni S; Beretta GD; Catalano V; Pucci F; Sobrero A; Tagliaferri P; Labi...anca R; Scartozzi M; Crocicchio F; Mari E; Ardizzoni A 2008-01-01 BRITISH JOURNAL OF CANCER - 1.04 Replica / breve intervento (e simili) -
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, ...Yarden Y, Lauriola M. 2018-01-01 CANCERS - 1.01 Articolo in rivista -
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956) Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaer...dt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G 2005-01-01 LUNG CANCER - 1.04 Replica / breve intervento (e simili) -
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, M...edoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N 2018-01-01 PLOS ONE - 1.01 Articolo in rivista journal.pone.0193689.pdf
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC) Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R....; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy 2018-01-01 CANCER - 1.01 Articolo in rivista -
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini... EM; Guazzi A; Ardizzoni A 2011-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.04 Replica / breve intervento (e simili) -
ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A 2010-01-01 ANNALS OF ONCOLOGY - 1.06 Abstract in rivista -
Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A 2011-01-01 CANCER - 1.04 Replica / breve intervento (e simili) -
Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial Guido, A; Cuicchi, D; Castellucci, P; Cellini, F; Di Fabio, F; Llimpe, FLR; Strigari, L; Buwenge,... M; Cilla, S; Deodato, F; Macchia, G; Galietta, E; Golfieri, R; Ardizzoni, A; Zagari, RM; Fanti, S; Poggioli, G; Fuccio, L; Morganti, AG 2022-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 1.01 Articolo in rivista -
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli..., Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco 2019-01-01 THE CLINICAL RESPIRATORY JOURNAL - 1.01 Articolo in rivista -
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranz...ano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio 2015-01-01 LUNG CANCER - 1.01 Articolo in rivista -